Compare $CELZ vs $KALA | Chartloom

Compare

$CELZ vs $KALA

Creative Medical Technology Holdings Inc · KALA BIO Inc

CELZ

Creative Medical Technology Holdings Inc

KALA

KALA BIO Inc

Compare $CELZ vs $KALA

Comparing Creative Medical Technology Holdings Inc and KALA BIO Inc

CELZCreative Medical Technology Holdings Inc

KALAKALA BIO Inc

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

KALAKALA BIO Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-99.1%

52W performance

-99.6%

FCF yield

-349.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELZ

KALA

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

KALA

KALA BIO Inc

Market Cap

CELZ$4M

KALA$6M

Enterprise Value

CELZ$-5M

KALA$5M

Price

CELZ$0.84

KALA$0.29

P/E Ratio

CELZN/A

KALAN/A

P/S Ratio

CELZ1,324.83x

KALA1.29x

EV/Sales

CELZ-1,579.87x

KALA1.26x

EV/EBITDA

CELZ0.00x

KALA0.00x

P/B Ratio

CELZ0.72x

KALA0.82x

P/FCF Ratio

CELZN/A

KALAN/A

EV/FCF

CELZ0.80x

KALA-0.27x

PEG Ratio

CELZN/A

KALAN/A

Forward P/E (NTM)

CELZN/A

KALAN/A

Forward P/S (NTM)

CELZN/A

KALAN/A

Revenue (TTM)

CELZ$3K

KALA$0

Revenue Growth (YoY)

CELZ-50.0%

KALAN/A

Forward Rev Growth

CELZ56.2%

KALA0.0%

Gross Margin (TTM)

CELZ66.7%

KALA31.0%

Operating Margin (TTM)

CELZ0.0%

KALA0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

KALA0.0%

Net Margin (TTM)

CELZ-201356.7%

KALA0.0%

FCF Margin (TTM)

CELZ-196726.7%

KALAN/A

Net Income (TTM)

CELZ$-6M

KALA$-10M

FCF (TTM)

CELZ$-6M

KALA$-20M

EPS (TTM)

CELZ-$1.63

KALA-$135.85

ROE (TTM)

CELZ-8670.0%

KALA-2816.0%

ROA (TTM)

CELZ-8196.0%

KALA-7023.0%

ROIC (TTM)

CELZ-8670.0%

KALA-2816.0%

Cash

CELZ$9M

KALA$229K

Debt

CELZ$0

KALA$0

Net Cash/Debt

CELZ$9M

KALA$229K

Current Ratio (TTM)

CELZ12.91x

KALA6.88x

Quick Ratio (TTM)

CELZ12.63x

KALA4.84x

Debt/Equity (TTM)

CELZ0.00x

KALA2.47x

Debt/Assets (TTM)

CELZ0.0%

KALA0.0%

Interest Coverage (TTM)

CELZN/A

KALAN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

KALA0.00x

Beta

CELZ1.93

KALA-2.48

52W Performance

CELZ-76.5%

KALA-99.6%

YTD Performance

CELZ-57.4%

KALA-99.1%

% from 52W High

CELZ-86.6%

KALA-99.7%

% from 52W Low

CELZ35.2%

KALA2.8%

Asset Turnover (TTM)

CELZ0.00x

KALA0.05x

FCF Yield (TTM)

CELZ-148.5%

KALA-349.4%

Earnings Yield (TTM)

CELZ-152.0%

KALA-177.3%

Dividend Yield (TTM)

CELZN/A

KALAN/A

Rule of 40

CELZ-196,776.7

KALA0.0

EV/GP/RG

CELZN/A

KALAN/A

Ticker research

View CELZ research View KALA research

Metric	CELZ Creative Medical Technology Holdings Inc	KALA KALA BIO Inc
Market & Valuation
Market Cap	$4M	$6M
Enterprise Value	$-5M	$5M
Price	$0.84	$0.29
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	1.29x
EV/Sales	-1,579.87x	1.26x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-0.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$0
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	31.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	0.0%
Net Margin (TTM)	-201356.7%	0.0%
FCF Margin (TTM)	-196726.7%	N/A
Net Income (TTM)	$-6M	$-10M
FCF (TTM)	$-6M	$-20M
EPS (TTM)	-$1.63	-$135.85
ROE (TTM)	-8670.0%	-2816.0%
ROA (TTM)	-8196.0%	-7023.0%
ROIC (TTM)	-8670.0%	-2816.0%
Financial Health
Cash	$9M	$229K
Debt	$0	$0
Net Cash/Debt	$9M	$229K
Current Ratio (TTM)	12.91x	6.88x
Quick Ratio (TTM)	12.63x	4.84x
Debt/Equity (TTM)	0.00x	2.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	-2.48
52W Performance	-76.5%	-99.6%
YTD Performance	-57.4%	-99.1%
% from 52W High	-86.6%	-99.7%
% from 52W Low	35.2%	2.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-148.5%	-349.4%
Earnings Yield (TTM)	-152.0%	-177.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View KALA research

Valuation

P/S Ratio

KALA

1.29x

CELZ

1,324.83x

EV/FCF

KALA

-0.27x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

CELZ

-50.0%

Forward Revenue Growth

CELZ

56.2%

KALA

0.0%

Profitability & performance

Gross Margin

CELZ

66.7%

KALA

31.0%

ROE

KALA

-2816.0%

CELZ

-8670.0%

FCF Yield %

CELZ

-148.5%

KALA

-349.4%

52-Week Performance

CELZ

-76.5%

KALA

-99.6%

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

KALA

KALA BIO Inc

Market Cap

CELZ$4M

KALA$6M

Enterprise Value

CELZ$-5M

KALA$5M

Price

CELZ$0.84

KALA$0.29

P/E Ratio

CELZN/A

KALAN/A

P/S Ratio

CELZ1,324.83x

KALA1.29x

EV/Sales

CELZ-1,579.87x

KALA1.26x

EV/EBITDA

CELZ0.00x

KALA0.00x

P/B Ratio

CELZ0.72x

KALA0.82x

P/FCF Ratio

CELZN/A

KALAN/A

EV/FCF

CELZ0.80x

KALA-0.27x

PEG Ratio

CELZN/A

KALAN/A

Forward P/E (NTM)

CELZN/A

KALAN/A

Forward P/S (NTM)

CELZN/A

KALAN/A

Revenue (TTM)

CELZ$3K

KALA$0

Revenue Growth (YoY)

CELZ-50.0%

KALAN/A

Forward Rev Growth

CELZ56.2%

KALA0.0%

Gross Margin (TTM)

CELZ66.7%

KALA31.0%

Operating Margin (TTM)

CELZ0.0%

KALA0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

KALA0.0%

Net Margin (TTM)

CELZ-201356.7%

KALA0.0%

FCF Margin (TTM)

CELZ-196726.7%

KALAN/A

Net Income (TTM)

CELZ$-6M

KALA$-10M

FCF (TTM)

CELZ$-6M

KALA$-20M

EPS (TTM)

CELZ-$1.63

KALA-$135.85

ROE (TTM)

CELZ-8670.0%

KALA-2816.0%

ROA (TTM)

CELZ-8196.0%

KALA-7023.0%

ROIC (TTM)

CELZ-8670.0%

KALA-2816.0%

Cash

CELZ$9M

KALA$229K

Debt

CELZ$0

KALA$0

Net Cash/Debt

CELZ$9M

KALA$229K

Current Ratio (TTM)

CELZ12.91x

KALA6.88x

Quick Ratio (TTM)

CELZ12.63x

KALA4.84x

Debt/Equity (TTM)

CELZ0.00x

KALA2.47x

Debt/Assets (TTM)

CELZ0.0%

KALA0.0%

Interest Coverage (TTM)

CELZN/A

KALAN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

KALA0.00x

Beta

CELZ1.93

KALA-2.48

52W Performance

CELZ-76.5%

KALA-99.6%

YTD Performance

CELZ-57.4%

KALA-99.1%

% from 52W High

CELZ-86.6%

KALA-99.7%

% from 52W Low

CELZ35.2%

KALA2.8%

Asset Turnover (TTM)

CELZ0.00x

KALA0.05x

FCF Yield (TTM)

CELZ-148.5%

KALA-349.4%

Earnings Yield (TTM)

CELZ-152.0%

KALA-177.3%

Dividend Yield (TTM)

CELZN/A

KALAN/A

Rule of 40

CELZ-196,776.7

KALA0.0

EV/GP/RG

CELZN/A

KALAN/A

Ticker research

View CELZ research View KALA research

Metric	CELZ Creative Medical Technology Holdings Inc	KALA KALA BIO Inc
Market & Valuation
Market Cap	$4M	$6M
Enterprise Value	$-5M	$5M
Price	$0.84	$0.29
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	1.29x
EV/Sales	-1,579.87x	1.26x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	0.82x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-0.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$0
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	31.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	0.0%
Net Margin (TTM)	-201356.7%	0.0%
FCF Margin (TTM)	-196726.7%	N/A
Net Income (TTM)	$-6M	$-10M
FCF (TTM)	$-6M	$-20M
EPS (TTM)	-$1.63	-$135.85
ROE (TTM)	-8670.0%	-2816.0%
ROA (TTM)	-8196.0%	-7023.0%
ROIC (TTM)	-8670.0%	-2816.0%
Financial Health
Cash	$9M	$229K
Debt	$0	$0
Net Cash/Debt	$9M	$229K
Current Ratio (TTM)	12.91x	6.88x
Quick Ratio (TTM)	12.63x	4.84x
Debt/Equity (TTM)	0.00x	2.47x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	-2.48
52W Performance	-76.5%	-99.6%
YTD Performance	-57.4%	-99.1%
% from 52W High	-86.6%	-99.7%
% from 52W Low	35.2%	2.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-148.5%	-349.4%
Earnings Yield (TTM)	-152.0%	-177.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View KALA research